RELMADA THERAPEUTICS INC shareholders Q3 2023

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
OCCUDO QUANTITATIVE STRATEGIES LP 22,941$68,8230.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 102,002$306,0060.01%
PDT Partners, LLC 14,920$44,7600.01%
BEDEL FINANCIAL CONSULTING INC 10,000$30,0000.01%
TIEDEMANN ADVISORS, LLC 31,715$95,1450.00%
MEYER HANDELMAN CO 32,545$97,6350.00%
Cutler Group LLC / CA 9,300$270.00%
PRELUDE CAPITAL MANAGEMENT, LLC 15,642$46,9260.00%
Hexagon Capital Partners LLC 4,000$12,0000.00%
Schonfeld Strategic Advisors LLC 109,310$327,9300.00%
Mirae Asset Global Investments Co., Ltd. 259,009$777,0270.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 125,846$377,5380.00%
GROUP ONE TRADING, L.P. 160,503$481,5090.00%
TWO SIGMA INVESTMENTS, LP 197,197$591,5910.00%
Stratos Wealth Partners, LTD. 16,000$48,0000.00%
Connor, Clark & Lunn Investment Management Ltd. 87,153$261,4590.00%
Lindbrook Capital, LLC 2,500$7,5000.00%
FEDERATED HERMES, INC. 114,202$342,6060.00%
Verition Fund Management LLC 34,334$103,0020.00%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 91,264$273,7920.00%
External links

This page lists RELMADA THERAPEUTICS INC's shareholders in Q3 2023. To view RELMADA THERAPEUTICS INC's shareholder history, click here.